Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.

Saved in:
Bibliographic Details
Title: Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
Authors: Paschen A; Clinical Cooperation Unit Dermato-Oncology, German Cancer Research Center Heidelberg and University Medicine Mannheim, University Medicine Mannheim, Mannheim, Germany. a.paschen@dkfz.de, Sucker A, Hill B, Moll I, Zapatka M, Nguyen XD, Sim GC, Gutmann I, Hassel J, Becker JC, Steinle A, Schadendorf D, Ugurel S
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2009 Aug 15; Vol. 15 (16), pp. 5208-15. Date of Electronic Publication: 2009 Aug 11.
Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-09-0886